|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Hamada T, Wakamatsu T, Miyahara M, et al:
MUC4: a novel prognostic factor of oral squamous cell carcinoma.
Int J Cancer. 130:1768–1776. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kruger M, Hansen T, Kasaj A and Moergel M:
The correlation between chronic periodontitis and oral cancer. Case
Rep Dent. 2013:2624102013.PubMed/NCBI
|
|
4
|
Forastiere A, Koch W, Trotti A and
Sidransky D: Head and neck cancer. N Engl J Med. 345:1890–1900.
2001. View Article : Google Scholar
|
|
5
|
Liang XH, Lewis J, Foote R, Smith D and
Kademani D: Prevalence and significance of human papillomavirus in
oral tongue cancer: the Mayo Clinic experience. J Oral Maxillofac
Surg. 66:1875–1880. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyn-geal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar
|
|
7
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
8
|
Chang WS, Lin CC, Chuang SC and Chiang HC:
Superoxide anion scavenging effect of coumarins. Am J Chin Med.
24:11–17. 1996. View Article : Google Scholar
|
|
9
|
Masamoto Y, Ando H, Murata Y, Shimoishi Y,
Tada M and Takahata K: Mushroom tyrosinase inhibitory activity of
esculetin isolated from seeds of Euphorbia lathyris L.
Biosci Biotechnol Biochem. 67:631–634. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin WL, Wang CJ, Tsai YY, Liu CL, Hwang JM
and Tseng TH: Inhibitory effect of esculetin on oxidative damage
induced by t-butyl hydroperoxide in rat liver. Arch Toxicol.
74:467–472. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Egan D, O’Kennedy R, Moran E, Cox D,
Prosser E and Thornes RD: The pharmacology, metabolism, analysis,
and applications of coumarin and coumarin-related compounds. Drug
Metab Rev. 22:503–529. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Okada Y, Miyauchi N, Suzuki K, et al:
Search for naturally occurring substances to prevent the
complications of diabetes. II Inhibitory effect of coumarin and
flavonoid derivatives on bovine lens aldose reductase and rabbit
platelet aggregation. Chem Pharm Bull (Tokyo). 43:1385–1387. 1995.
View Article : Google Scholar
|
|
13
|
Wang CJ, Hsieh YJ, Chu CY, Lin YL and
Tseng TH: Inhibition of cell cycle progression in human leukemia
HL-60 cells by esculetin. Cancer Lett. 183:163–168. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kok SH, Yeh CC, Chen ML and Kuo MY:
Esculetin enhances TRAIL-induced apoptosis through DR5 upregulation
in human oral cancer SAS cells. Oral Oncol. 45:1067–1072. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Noguchi M, Kitagawa H, Miyazaki I and
Mizukami Y: Influence of esculetin on incidence, proliferation, and
cell kinetics of mammary carcinomas induced by
7,12-dimethylbenz[a]anthracene in rats on high- and low-fat diets.
Jpn J Cancer Res. 84:1010–1014. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Davie JR, He S, Li L, et al: Nuclear
organization and chromatin dynamics-Sp1, Sp3 and histone
deacetylases. Adv Enzyme Regul. 48:189–208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chuang JY, Wu CH, Lai MD, Chang WC and
Hung JJ: Overexpression of Sp1 leads to p53-dependent apoptosis in
cancer cells. Int J Cancer. 125:2066–2076. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen L, Liu Q, Qin R, et al: Amplification
and functional characterization of MUC1 promoter and
gene-virotherapy via a targeting adenoviral vector expressing
hSSTR2 gene in MUC1-positive Panc-1 pancreatic cancer cells in
vitro. Int J Mol Med. 15:617–626. 2005.PubMed/NCBI
|
|
19
|
Kong LM, Liao CG, Fei F, Guo X, Xing JL
and Chen ZN: Transcription factor Sp1 regulates expression of
cancer-associated molecule CD147 in human lung cancer. Cancer Sci.
101:1463–1470. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sankpal UT, Goodison S, Abdelrahim M and
Basha R: Targeting Sp1 transcription factors in prostate cancer
therapy. Med Chem. 7:518–525. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chae JI, Jeon YJ and Shim JH:
Downregulation of Sp1 is involved in honokiol-induced cell cycle
arrest and apoptosis in human malignant pleural mesothelioma cells.
Oncol Rep. 29:2318–2324. 2013.PubMed/NCBI
|
|
22
|
Kim DW, Ko SM, Jeon YJ, et al:
Anti-proliferative effect of honokiol in oral squamous cancer
through the regulation of specificity protein 1. Int J Oncol.
43:1103–1110. 2013.PubMed/NCBI
|
|
23
|
Chae JI, Cho JH, Lee KA, et al: Role of
transcription factor Sp1 in the quercetin-mediated inhibitory
effect on human malignant pleural mesothelioma. Int J Mol Med.
30:835–841. 2012.PubMed/NCBI
|
|
24
|
Jeon YJ, Ko SM, Cho JH, Chae JI and Shim
JH: The HDAC inhibitor, panobinostat, induces apoptosis by
suppressing the expresssion of specificity protein 1 in oral
squamous cell carcinoma. Int J Mol Med. 32:860–866. 2013.PubMed/NCBI
|
|
25
|
Kawase M, Sakagami H, Hashimoto K, Tani S,
Hauer H and Chatterjee SS: Structure-cytotoxic activity
relationships of simple hydroxylated coumarins. Anticancer Res.
23:3243–3246. 2003.PubMed/NCBI
|
|
26
|
Tubaro A, Del Negro P, Ragazzi E, Zampiron
S and Della Loggia R: Anti-inflammatory and peripheral analgesic
activity of esculetin in vivo. Pharmacol Res Commun. 20(Suppl 5):
83–85. 1988. View Article : Google Scholar
|
|
27
|
Huang HC, Lai MW, Wang HR, Chung YL, Hsieh
LM and Chen CC: Antiproliferative effect of esculetin on vascular
smooth muscle cells: possible roles of signal transduction
pathways. Eur J Pharmacol. 237:39–44. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matsunaga K, Yoshimi N, Yamada Y, et al:
Inhibitory effects of nabumetone, a cyclooxygenase-2 inhibitor, and
esculetin, a lipoxygenase inhibitor, on
N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats. Jpn
J Cancer Res. 89:496–501. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hecht SS, Kenney PM, Wang M, et al:
Evaluation of butylated hydroxyanisole, myo-inositol, curcumin,
esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene
plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung
tumorigenesis in A/J mice. Cancer Lett. 137:123–130. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Martin-Aragon S, Benedi JM and Villar AM:
Effects of the anti-oxidant (6,7-dihydroxycoumarin) esculetin on
the glutathione system and lipid peroxidation in mice. Gerontology.
44:21–25. 1998. View Article : Google Scholar : PubMed/NCBI
|
